...
机译:口服二十二碳五烯酸(22:5n-3)被差异化地整合到磷脂池中,并被新陈代谢的组织中差异代谢成二十碳五烯酸。
Department of Human Biology and Nutritional Sciences, Animal Science and Nutrition Building, University of Guelph, Guelph, ON, N1G 2W1, Canada;
Department of Human Biology and Nutritional Sciences, Animal Science and Nutrition Building, University of Guelph, Guelph, ON, N1G 2W1, Canada;
Department of Human Biology and Nutritional Sciences, Animal Science and Nutrition Building, University of Guelph, Guelph, ON, N1G 2W1, Canada;
Docosapentaenoic acid (DPA 22:5n-3); Rat serum; Cholesteryl esters; Triacylglycerol(s); Liver; Heart; Kidney; Apparent retroconversion; Eicosapentaenoic acid (EPA 20:5n-3); Individual phospholipids;
机译:口服二十碳五烯酸(22:5n-3)被差异地掺入磷脂池中,并在年轻大鼠的组织中差异代谢为二十碳五烯酸。
机译:大鼠中二十二碳五烯酸(DPA,22:5N-3)和二十碳五烯酸(EPA,20:5n-3)的生物利用度比较
机译:雌二醇有利于SH-SY5Y神经母细胞瘤细胞中α-亚麻酸(18:3n-3)形成二十碳五烯酸(20:5n-3)和n-3二十碳五烯酸(22:5n-3)
机译:100至20℃的长链多不饱和脂肪酸二十碳五烯酸(DPA,22:5n-6)和二十二碳六烯酸(DHA; 22:6n-3)的连续梯度温度拉曼光谱
机译:Eicosapentaeno酸和二糖六烯酸差异调节慢性炎症中的单核细胞:随机临床试验
机译:人类细胞中二十二碳六烯酸(DHA; 22:6n-3)的代谢命运:DHA直接逆转换为二十碳五烯酸(EPA; 20:5n-3)在延伸至四二十碳六烯酸(THA; 24:6n-3)方面占主导地位
机译:短期二十碳五烯酸(22:5n-3)补充可增加大鼠体内二十二碳五烯酸,DHA和EPA的浓度